Item
Theobromine (Theobm)
The ingredient is theobromine, the assay is 99.0%~101.0%.
Sweetener
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| CSPC Innovation Pharmaceutical Co., Ltd. | No. 62 Zhangju Road Luancheng County Shijiazhuang City, Hebei Province 050000 CHN |
| Fuller Enterprise USA Inc. | 1735 E. Grevillea Ct. Ontario, CA 91761 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| CoA Sample | Fuller Enterprise USA Inc. | 5032106006.pdf | 6/1/2021 | 6/1/2023 |
| Allergens | CSPC Innovation Pharmaceutical Co., Ltd. | Allergens.pdf | 2/10/2023 | 2/9/2025 |
| BSE - TSE | Fuller Enterprise USA Inc. | BSE.TSE Free Statement.pdf | 1/18/2022 | 1/17/2025 |
| BSE - TSE | CSPC Innovation Pharmaceutical Co., Ltd. | BSE.TSE Free Statement.pdf | 1/18/2022 | 1/18/2027 |
| Ingredient Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Composition Statement.pdf | 2/1/2021 | 2/1/2026 |
| Country of Origin | Fuller Enterprise USA Inc. | Country of Origin.pdf | 5/19/2020 | 5/19/2023 |
| Country of Origin | CSPC Innovation Pharmaceutical Co., Ltd. | Country of Origin.pdf | 2/10/2023 | 2/9/2026 |
| HACCP Process Flow Diagram | CSPC Innovation Pharmaceutical Co., Ltd. | Flow Chart with CCPs.pdf | 2/10/2023 | 2/9/2025 |
| Gluten | Fuller Enterprise USA Inc. | Gluten Free Statement.pdf | 1/18/2022 | 1/18/2023 |
| Gluten | CSPC Innovation Pharmaceutical Co., Ltd. | Gluten Free Statement.pdf | 1/18/2022 | 1/18/2027 |
| GRAS/NDI/ODI Statement | CSPC Innovation Pharmaceutical Co., Ltd. | GRAS Statement.pdf | 2/10/2023 | 2/10/2028 |
| HACCP | Fuller Enterprise USA Inc. | HACCP Plan.pdf | 2/2/2021 | 2/2/2024 |
| Kosher | Fuller Enterprise USA Inc. | Kosher - 20220831.pdf | 8/31/2022 | |
| Kosher | CSPC Innovation Pharmaceutical Co., Ltd. | Kosher Certificate - 2023.08.31.pdf | 8/28/2022 | 8/31/2023 |
| Label Sample | Fuller Enterprise USA Inc. | Label Example.jpg | 7/22/2022 | 7/22/2025 |
| Irradiation Status Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Non-ETO.Non-Chemical Sterilization Statement.pdf | 1/18/2022 | 1/18/2027 |
| EtO Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Non-ETO.Non-Chemical Sterilization Statement.pdf | 1/18/2022 | 1/18/2024 |
| Irradiation Status Statement | Fuller Enterprise USA Inc. | Non-Irradiation Statement.pdf | 1/18/2022 | 1/18/2024 |
| Allergens | Fuller Enterprise USA Inc. | NotApplicable_Allergens.pdf | 12/9/2022 | 12/8/2024 |
| HACCP Process Flow Diagram | Fuller Enterprise USA Inc. | NotApplicable_HACCPProcessFlowDiagram.pdf | 12/9/2022 | 12/8/2024 |
| Ingredient Statement | Fuller Enterprise USA Inc. | NotApplicable_IngredientStatement.pdf | 2/10/2023 | 2/10/2024 |
| Item Questionnaire | Fuller Enterprise USA Inc. | NotApplicable_ItemQuestionnaire.pdf | 2/11/2023 | 2/10/2026 |
| Nutrition | Fuller Enterprise USA Inc. | Nutrition.pdf | 6/30/2020 | 6/30/2023 |
| Pesticide | Fuller Enterprise USA Inc. | Pesticides Free Statement.pdf | 1/18/2022 | 1/18/2024 |
| California Prop. 65 | Fuller Enterprise USA Inc. | Prop 65 Statement.pdf | 2/24/2021 | 2/24/2023 |
| California Prop. 65 | CSPC Innovation Pharmaceutical Co., Ltd. | Prop 65 Statement.pdf | 4/1/2021 | 4/1/2025 |
| Residual Statement | Fuller Enterprise USA Inc. | Residual Solvent.Solvents Used Statement.pdf | 1/18/2022 | 1/18/2023 |
| Residual Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Residual Solvent.Solvents Used Statement.pdf | 1/18/2022 | 1/18/2026 |
| Safety Data Sheet (SDS) | Fuller Enterprise USA Inc. | SDS.pdf | 1/18/2022 | 1/18/2024 |
| Safety Data Sheet (SDS) | CSPC Innovation Pharmaceutical Co., Ltd. | SDS.pdf | 5/20/2020 | 5/20/2027 |
| Sewage Statement | CSPC Innovation Pharmaceutical Co., Ltd. | Sewage Sludge Statement.pdf | 2/10/2023 | 2/10/2027 |
| Product Specification Sheet | Fuller Enterprise USA Inc. | Specification Sheet.pdf | 7/13/2021 | 7/12/2024 |
| Product Specification Sheet | CSPC Innovation Pharmaceutical Co., Ltd. | Specification Sheet.pdf | 2/10/2023 | 2/10/2028 |
| Suitability Requirements | Fuller Enterprise USA Inc. | Suitability Requirements.pdf | 5/21/2020 | 5/21/2023 |
| Halal | Fuller Enterprise USA Inc. | Theobromine Halal Questionnaire.pdf | 11/7/2021 | |
| WADA/NSF/NFL Statement | Fuller Enterprise USA Inc. | WADA Statement.pdf | 2/2/2021 | 2/2/2023 |
